Company Filing History:
Years Active: 2019
Title: Irmgard Hofmann: Innovator in Cytomegalovirus Vaccine Development
Introduction
Irmgard Hofmann is a notable inventor based in Vienna, Austria. She has made significant contributions to the field of biotechnology, particularly in the development of vaccines. Her work focuses on cytomegalovirus (CMV) proteins, which are crucial for vaccine applications.
Latest Patents
Irmgard Hofmann holds a patent for "Mammalian cells expressing cytomegalovirus antigens." This invention relates to the use of cytomegalovirus proteins suitable for vaccine development. The patent describes mammalian host cells, specifically CHO cells, that have stably integrated sequences encoding CMV proteins gH, gL, pUL128, pUL130, and pUL131 into their genome.
Career Highlights
Irmgard is associated with GlaxoSmithKline Biologicals SA, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of CMV and its implications for vaccine technology.
Collaborations
Irmgard has collaborated with esteemed colleagues such as Andrea Carfi and Claudio Ciferri. These partnerships have enhanced her research and contributed to the success of her innovations.
Conclusion
Irmgard Hofmann's contributions to the field of vaccine development, particularly regarding cytomegalovirus, highlight her role as a leading inventor in biotechnology. Her work continues to pave the way for advancements in vaccine technology.